SK

Suresh Kumar

Active Director Designated Partner DIN 10664895
DIN 10664895 First appointment Jul 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Suresh Kumar

Data last updated:

Suresh Kumar is a Designated Partner at Accvus Pharmaceuticals Llp (since 2024). The company operates in Paper.

DIN 10664895
Primary Designation Designated Partner
Industry Paper
First Appointment 13 Jul 2024
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner13 Jul 20242023Active

Board colleagues of Suresh Kumar

NameDINCompanyDesignation
Gandhi Maruthupandi10037749Accvus Pharmaceuticals LlpDesignated Partner
Ganesh Raj09258773Accvus Pharmaceuticals LlpDesignated Partner
Nagajothi10037750Accvus Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Accvus Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Suresh Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Kumar

Suresh Kumar currently holds 1 directorship: Accvus Pharmaceuticals Llp (Designated Partner, since 13 Jul 2024).

Suresh Kumar was first appointed on 13 Jul 2024 as Designated Partner at Accvus Pharmaceuticals Llp.

The current boards of Suresh Kumar's companies include Gandhi Maruthupandi (Accvus Pharmaceuticals Llp), Ganesh Raj (Accvus Pharmaceuticals Llp), Nagajothi (Accvus Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available